Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|October 17, 2017
Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic ReviewCharissa A C Jessurun, Julien A M Vos, Jacqueline Limpens, et al.
Neuro-Oncology Advances|December 3, 2021
Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysisIshaan Ashwini Tewarie, Charissa A C Jessurun, Alexander F C Hulsbergen, et al.
World Neurosurgery|December 27, 2021
Practice Variation in Perioperative Steroid Dosing for Brain Tumor Patients: An International SurveyCharissa A C Jessurun, Alexander F C Hulsbergen, Nayan Lamba, et al.
Journal of Neuro-Oncology|July 27, 2019
Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?Charissa A C Jessurun, Alexander F C Hulsbergen, Logan D Cho, et al.
World Neurosurgery|August 26, 2022
Risk Factors of Second Local Recurrence in Surgically Treated Recurrent Brain Metastases: An Exploratory AnalysisIshaan Ashwini Tewarie, Alexander F C Hulsbergen, Charissa A C Jessurun, et al.
Journal of Neuro-Oncology|February 7, 2025
Hyperprogression of brain metastases following initiation of immune checkpoint inhibitorsCharissa A C Jessurun, Francesca Siddi, Noah L A Nawabi, et al.
Journal of Neurosurgery|October 22, 2022
Predicting leptomeningeal disease spread after resection of brain metastases using machine learningIshaan Ashwini Tewarie, Alexander W Senko, Charissa A C Jessurun, et al.
Neuro-Oncology|February 25, 2021
The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysisCharissa A C Jessurun, Alexander F C Hulsbergen, Anouk E de Wit, et al.
Neurosurgery|June 23, 2025
Impact of Extent of Resection on Survival in Brain Metastasis: An Analysis of 867 PatientsAlexander F C Hulsbergen, Francesca Siddi, Christian Cerecedo, et al.
Pageof 2